A carregar...

Impact of Biosimilar Insulins on Clinical Practice: Meeting Report

The availability of biosimilar insulins can potentially lead to lower insulin costs and increased access for patients with diabetes, worldwide. However, clinicians and regulatory agencies have raised several concerns regarding the safety and efficacy of these new medications. The European regulatory...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Sci Technol
Main Authors: Dolinar, Richard O., Edelman, Steve, Heinemann, Lutz, Home, Philip, Goyal, Shefali, Polonsky, William H., Schellekens, Huub
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4454104/
https://ncbi.nlm.nih.gov/pubmed/24876554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296813518267
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!